Servier found guilty of fraud in trial over pulled weight loss drug Mediator, reversing earlier ruling

The French drug company Servier has been ordered to pay another hefty fine for its role in a scandal related to its weight loss drug Mediator, a French court ruled Wednesday.

The company must pay €430 million ($470 million) after being found guilty of fraud. Servier sold Mediator while knowing it was potentially harmful to customers, the court found, reversing an earlier ruling which had acquitted the company of the charge.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

How safe are GLP-1R agonists in early pregnancy?

JAMA Internal Medicine study examines the safety of GLP-1 receptor agonists and other second-line antidiabetic medications during early pregnancy, finding no significant increase in congenital

December 14, 2023

10 Key 2023 Psychedelic Studies Reveal Optimal Psilocybin Doses for Depression

Psychedelic research is flourishing again, and mainstream Americans may soon feel its impact. MDMA is near the regulatory finish line thanks to MAPS’s recent new

December 13, 2023

In absence of Roe v. Wade, an abortion doctor dwells on all the patients she does not see

Last year, just a few months after the Supreme Court’s reversal of Roe v. Wade ended the constitutional right to abortion in the United States,

June 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.